Opiant Pharmaceuticals Inc (OPNT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2021 | 12-2020 | 12-2019 | 12-2018 | 12-2017 | |
| Sales | 47,786 | 29,625 | 40,520 | 13,982 | 0 |
| Gross Profit | 47,786 | 29,625 | 40,520 | 13,982 | N/A |
| Operating Expenses | 42,629 | 31,866 | 29,608 | 35,173 | 0 |
| Operating Income | 5,156 | -2,241 | 10,912 | -21,190 | N/A |
| Interest Expense | 2,129 | 131 | 0 | 0 | 0 |
| Other Income | 6 | 85 | 504 | 46 | 0 |
| Pre-tax Income | 3,033 | -2,287 | 11,416 | -21,144 | 0 |
| Income Tax | 24 | -426 | -177 | 51 | N/A |
| Net Income Continuous | 3,009 | -1,861 | 11,593 | -21,195 | N/A |
| Net Income | $3,009 | $-1,861 | $11,593 | $-21,195 | $N/A |
| EPS Basic Total Ops | 0.68 | -0.44 | 2.88 | -7.10 | N/A |
| EPS Basic Continuous Ops | 0.68 | -0.44 | 2.89 | -7.10 | N/A |
| EPS Diluted Total Ops | 0.51 | -0.44 | 2.17 | -7.10 | N/A |
| EPS Diluted Continuous Ops | 0.51 | -0.44 | 2.17 | -7.10 | N/A |
| EPS Diluted Before Non-Recurring Items | 0.51 | -0.44 | 0.20 | -7.10 | 2.94 |
| EBITDA(a) | $6,086 | $-1,616 | $11,149 | $-21,188 | $N/A |